⌘K

Home/Filings/4/0001641172-25-016113

4//SEC Filing

Marquet Magda 4

Accession 0001641172-25-016113

CIK 0001873835other

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 4:57 PM ET

Size

6.9 KB

Accession

0001641172-25-016113

Insider Transaction Report

Form 4

Period: 2025-06-20

Immix Biopharma, Inc.IMMX

Director

Transactions

Award
Stock Option (Right to Buy)
2025-06-20+33,000→ 33,000 total
Exercise: $2.24Exp: 2035-06-20→ Common Stock (33,000 underlying)

Holdings

Common Stock
46,092
Common Stock
(indirect: By LLC)
20,000

Footnotes (1)

[F1]The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1

filerCIK 0001631486

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 4:57 PM ET
Size: 6.9 KB

View on SEC.gov